- Home
- RNW vs HCM Comparison
RNW vs HCM Comparison
Compare RNW & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNW | HCM |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | United Kingdom | Hong Kong |
| Employees | 4336 | 1796 |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RNW | HCM |
|---|---|---|
| Price | $6.34 | $10.74 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $13.75 |
| AVG Volume (30 Days) | ★ 1.4M | 55.8K |
| Earning Date | 06-15-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.60 |
| Revenue Next Year | $11.50 | $15.62 |
| P/E Ratio | $14.63 | ★ $5.49 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.39 | $10.40 |
| 52 Week High | $8.24 | $19.50 |
Technical Indicators
Market Signals| Indicator | RNW | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 62.39 | 25.25 |
| Support Level | $5.20 | N/A |
| Resistance Level | $7.79 | $15.59 |
| Average True Range (ATR) | 0.23 | 0.33 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 65.79 | 17.42 |
Price Performance
Historical ComparisonAbout RNW ReNew Energy Global plc
ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.